Use of high-throughput methods for early stage formulation evaluation and their correlation to stability studies

AbbVie preformulation is an early discovery biologics group working to optimise antibodies prior to downstream assays and clinical delivery.

Join Brittney Mills, PhD, as she explains how AbbVie uses the Prometheus to evaluate conformational and colloidal stability of their candidates. She will discuss the goals of their early formulations group; how Prometheus nanoDSF compares to DSC and its advantages in material usage; the predictive merits of data derived from Prometheus; and how accelerated stability studies validate the initial screening parameters.

Previous Article
How stability studies get your mAb candidate FDA-approved
How stability studies get your mAb candidate FDA-approved

Up next
5 experiments in biologics that can be improved with dynamic light scattering
5 experiments in biologics that can be improved with dynamic light scattering

Biologics, which are drugs and treatments derived from natural products, undergo a long development process...

Want to see more
biologics content?

Explore resources